LINC01559 and renal cell carcinoma: Among the six selected ARlncRNAs, LINC01559 was reported to be upregulated in renal cell carcinoma, gastric cancer, PC, and hepatocellular carcinoma (Chen B. et al., 2018; Chen et al., 2020; Dong et al., 2020; Lou et al., 2020; Wang et al., 2020).